These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19307229)

  • 1. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease.
    Beddhu S; Nigwekar SU; Ma X; Greene T
    Nephrol Dial Transplant; 2009 Aug; 24(8):2482-8. PubMed ID: 19307229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.
    Matsushita K; Selvin E; Bash LD; Astor BC; Coresh J
    Am J Kidney Dis; 2010 Apr; 55(4):648-59. PubMed ID: 20189275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.
    Navaneethan SD; Beddhu S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1260-6. PubMed ID: 19033255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease.
    Kang SY; Lee YH; Jeong SJ; Kim JS; Jeong KH; Hwang HS
    Nephrol Dial Transplant; 2024 Apr; 39(5):778-787. PubMed ID: 37791396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between resting heart rate just before starting the first dialysis session and mortality: A multicentre prospective cohort study.
    Inaguma D; Koide S; Takahashi K; Hayashi H; Hasegawa M; Yuzawa Y;
    Nephrology (Carlton); 2018 May; 23(5):461-468. PubMed ID: 28332737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.
    Di Angelantonio E; Chowdhury R; Sarwar N; Aspelund T; Danesh J; Gudnason V
    BMJ; 2010 Sep; 341():c4986. PubMed ID: 20884698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated resting heart rate is associated with mortality in patients with chronic kidney disease.
    Saito H; Tanaka K; Ejiri H; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Sci Rep; 2024 Jul; 14(1):17372. PubMed ID: 39075101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.
    Pammer LM; Lamina C; Schultheiss UT; Kotsis F; Kollerits B; Stockmann H; Lipovsek J; Meiselbach H; Busch M; Eckardt KU; Kronenberg F;
    J Intern Med; 2021 Dec; 290(6):1219-1232. PubMed ID: 34342064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid and long-term outcomes in CKD.
    Madero M; Sarnak MJ; Wang X; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
    Am J Kidney Dis; 2009 May; 53(5):796-803. PubMed ID: 19303683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
    Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.
    Vassallo D; Ritchie J; Green D; Chrysochou C; Blunt J; Kalra PA
    BMC Nephrol; 2016 Dec; 17(1):198. PubMed ID: 27927187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study.
    Verhagen SN; Wassink AM; van der Graaf Y; Gorter PM; Visseren FL;
    Cardiovasc Diabetol; 2011 Nov; 10():100. PubMed ID: 22098712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.
    Weiner DE; Tabatabai S; Tighiouart H; Elsayed E; Bansal N; Griffith J; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2006 Sep; 48(3):392-401. PubMed ID: 16931212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study.
    Hashemi A; Nourbakhsh S; Asgari S; Mirbolouk M; Azizi F; Hadaegh F
    J Transl Med; 2018 Aug; 16(1):230. PubMed ID: 30111315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
    Weiner DE; Tighiouart H; Amin MG; Stark PC; MacLeod B; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2004 May; 15(5):1307-15. PubMed ID: 15100371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function and discrimination of cardiovascular risk in middle-aged men.
    Soveri I; Arnlöv J; Berglund L; Lind L; Fellström B; Sundström J
    J Intern Med; 2009 Oct; 266(4):406-13. PubMed ID: 19500212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting clinical outcomes after coronary artery bypass surgery: analysis of patients with chronic kidney disease after 5.9 years of follow-up.
    Orii K; Hioki M; Iedokoro Y; Shimizu K
    J Nippon Med Sch; 2011; 78(3):156-65. PubMed ID: 21720089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.